MedPath

Risk calculation for Pre-Eclampsie and Grwoth Restriction in the First Trimester

Completed
Conditions
Pre-eclampsia - New-onset Hypertension and Proteinuria in Pregnancy
10010273
10057166
Registration Number
NL-OMON39085
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
3000
Inclusion Criteria

Primigravida
Viable singleton pregnancy < 12 weeks of gestation
Informed consent given

Exclusion Criteria

Minors (being under the age of 18)
Incapacitated persons
Not mastering the Dutch language

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main objective of the study is to evaluate the performance of two existing<br /><br>algorithms for the prediction of PE and growth restriction not associated with<br /><br>PE. These algorithms (including the following variables: ethnicity, body mass<br /><br>index (BMI), mean arterial pressure (MAP), lowest Doppler resistance<br /><br>measurement (PI) of both uterine arteries and maternal serum blood markers<br /><br>(PAPP-A and PLGF)) will be tested and other possible combinations of variables<br /><br>will be evaluated for their predictive ability. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary objectives:<br /><br>- Evaluating the learning curve for measurement of the uterine arteries<br /><br>- Inter and intra- observer variation of measurement of the uterine arteries<br /><br>- Quality assessment of the measurements of the uterine arteries<br /><br>- Time needed to collect informed consent, maternal history and measurement of<br /><br>the maternal blood pressure and uterine arteries </p><br>
© Copyright 2025. All Rights Reserved by MedPath